Director of Canada’s drug price regulator resigns same week as colleague steps down – CTV

Feb. 25, 2023

HALIFAX – The executive director of Canada’s drug pricing regulator is stepping down — just days after another member resigned because of concerns that the federal government was undermining the independent body’s work.
Douglas Clark, with the Patented Medicine Prices Review Board, announced Friday he would be leaving his post after almost a decade with the regulator that oversees the prices of medicines sold in Canada.

His short statement, issued by the regulator’s media relations office, did not state why he was leaving. The regulator “wishes to thank Mr. Clark for his years of dedicated service and leadership,” the release said.

A day earlier, Matthew Herder, a professor of health law at Dalhousie University, announced he had resigned from the board, accusing the federal government of failing to implement critically important reforms that could lower the cost of medication.

Read more:

NationTalk Partners & Sponsors Learn More